Page last updated: 2024-11-13

coumachlor

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

coumachlor: C19-H15-Cl-O4 [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID54682651
CHEMBL ID1272169
CHEBI ID80741
SCHEMBL ID1477912
SCHEMBL ID433455
MeSH IDM0368708

Synonyms (91)

Synonym
LS-14700
3-(alpha-acetonyl-4-chlorobenzyl)-4-hydroxycoumarin
tomorin
coumachlore [french]
3-(1-(4-chloorfenyl)-3-oxo-butyl)-4-hydroxy-cumarine [dutch]
brn 1689759
3-(1-acetyl-2-(p-chlorophenyl)ethyl)-4-hydroxycoumarin
ratilan
cumachlor [german]
experimental rodenticide 332
3-(alpha-(p-chlorphenyl)-beta-acetylaethyl)-4-hydroxycumarin [german]
coumachlor
coumachlor [iso:bsi]
cumachloor [dutch]
coumachlore [iso-french]
epa pesticide chemical code 224200
3-(1-(4-chlorophenyl)-3-oxobutyl)-4-hydroxy-2h-1-benzopyran-2-one
3-(1-(4-chlorophenyl)-3-oxobutyl)-4-hydroxycoumarin
3-(1-(4-chlor-phenyl)-3-oxo-butyl)-4-hydroxy-cumarin [german]
hsdb 7116
3-(1-(4-cloro-fenil)-3-oxo-butil)-4-idrossicumarina [italian]
2h-1-benzopyran-2-one, 3-(1-(4-chlorophenyl)-3-oxobutyl)-4-hydroxy-
3-(alpha-p-chlorophenyl-beta-acetylethyl)-4-hydroxycoumarin
kumachlor [czech]
coumarin, 3-(alpha-acetonyl-p-chlorobenzyl)-4-hydroxy-
3-(1-(4-chlorophenyl)-3-oxo-butyl)-4-hydroxy-coumarine [french]
4-hydroxy-3-(1-(4-chlorophenyl)-3-oxobutyl)-2h-1-benzopyran-2-one
caswell no. 004a
g-23133
einecs 201-378-1
3-(alpha-acetonyl-p-chlorobenzyl)-4-hydroxycoumarin
geigy rodenticide exp. 332
cumachlor
coumachlor, 98%
ZINC03875546
81-82-3
coumachlore
kumachlor
3-((alpha-acetonyl)-4-chlorbenzyl)-4-hydroxycumarin [iupac]
3-(alpha-(p-chlorphenyl)-beta-acetylaethyl)-4-hydroxycumarin
5-18-04-00163 (beilstein handbook reference)
3-((alpha-acetonyl)-4-chlorbenzyl)-4-hydroxycumarin
ucd8xzw42p ,
3-(1-(4-chlor-phenyl)-3-oxo-butyl)-4-hydroxy-cumarin
unii-ucd8xzw42p
3-(1-(4-chlorophenyl)-3-oxo-butyl)-4-hydroxy-coumarine
3-(1-(4-cloro-fenil)-3-oxo-butil)-4-idrossicumarina
cumachloor
3-(1-(4-chloorfenyl)-3-oxo-butyl)-4-hydroxy-cumarine
NCGC00255455-01
dtxsid8041797 ,
tox21_301860
cas-81-82-3
dtxcid6021797
chebi:80741 ,
CHEMBL1272169
SCHEMBL1477912
AKOS015962273
3-[1-(4-chlorophenyl)-3-oxobutyl]-4-hydroxychromen-2-one
FT-0631370
p-chlorowarfarin
SCHEMBL433455
famarin
AM85918
3-(1-(4-chlorophenyl)-3-oxobutyl)-4-hydroxy-2h-chromen-2-one
3-(.alpha.-p-chlorophenyl-.beta.-acetylethyl)-4-hydroxycoumarin
3-(.alpha.-acetonyl-p-chlorobenzyl)-4-hydroxycoumarin
dl-3-(.alpha.-acetonyl-4-chlorobenzyl)-4-hydroxycoumarin
(.+/-.)-coumachlor
coumarin, 3-(.alpha.-acetonyl-p-chlorobenzyl)-4-hydroxy-
3-[1-(4-chlorophenyl)-3-oxobutyl]-4-hydroxy-2h-chromen-2-one #
3-(.alpha.-(p-chlorphenyl)-.beta.-acetylaethyl)-4-hydroxycumarin
3-(.alpha.-acetonyl-4-chlorobenzyl)-4-hydroxycoumarin
DEKWZWCFHUABHE-UHFFFAOYSA-N
4-hydroxy-3-[3-oxo-1-(4-chlorophenyl)butyl]coumarin
2h-1-benzopyran-2-one, 3-[1-(4-chlorophenyl)-3-oxobutyl]-4-hydroxy-
dl-3-(alpha-acetonyl-4'-chlorobenzyl)-4-hydroxycoumarin
3-(1-(p-chlorophenyl)-2-acetylethyl)-4-hydroxycoumarin
3-(.alpha.-acetonyl-4-chlorobenzyl)-4-hydroxy coumarin, (+/-)-
3-((.alpha.-acetonyl)-4-chlorbenzyl)-4-hydroxycumarin [hsdb]
coumachlor [mi]
p-chlorowarfarin, (+/-)-
coumachlor, (+/-)-
coumachlor [iso]
AC-22308
coumachlor, pestanal(r), analytical standard
mfcd00012094
Q5176191
H10531
(+/-)-3-(alpha-acetonyl-p-chlorobenzyl)-4-hydroxycoumarin
CS-W013916
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
hydroxycoumarinAny coumarin carrying at least one hydroxy substituent.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (2)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
peroxisome proliferator activated receptor gammaHomo sapiens (human)Potency15.55500.001019.414170.9645AID743094; AID743140
Histone H2A.xCricetulus griseus (Chinese hamster)Potency118.60500.039147.5451146.8240AID1224845
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID528386Displacement of [3H](S)-warfarin from methacrylic acid-ethylene dimethacrylate copolymer2010Journal of medicinal chemistry, Nov-25, Volume: 53, Issue:22
Synthetic human serum albumin Sudlow I binding site mimics.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (13)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (15.38)18.7374
1990's0 (0.00)18.2507
2000's5 (38.46)29.6817
2010's6 (46.15)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 25.71

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index25.71 (24.57)
Research Supply Index2.71 (2.92)
Research Growth Index5.09 (4.65)
Search Engine Demand Index26.67 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (25.71)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other14 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]